◆ 会议时间：2021年6月2日至5日
◆ 会议地点：虚拟会议

◆ 会议简介：

2021年欧洲风湿病学大会（EULAR年会）将于2021年6月2日至5日以虚拟会议举行，会议由欧洲抗风湿病联盟(EULAR)主办。一年一度的EULAR大会是世界风湿病学日历中的重大事件，大会将汇集来自欧洲和世界各地的医师、科学家，各年龄段的患者及其家属，卫生保健专业人士和制药行业代表；一系列多样化的EULAR活动将展示传播风湿病学领域的最新研究进展，所有活动都致力于改善风湿性骨骼肌肉疾病或受其影响的人们的健康状况。2021年EULAR大会将再次讨论广泛的议题，包括人口、卫生服务、临床、转化和基础科学等方面的创新，致力于欧洲关节炎和风湿病患者（PARE）和风湿病卫生专业人员（HPR）的会议将成为一个突出特色！并将再次提供高质量的卫生保健行业会议，提供深入和有重点的见解。

欧洲风湿病学大会(EULAR大会)起源于2000年，现已成为欧洲科学和临床信息交流的重要平台，是医生、科学家、关节炎/风湿病患者、卫生专业人员和全球医药行业代表之间互相交流的知名论坛，EULAR大会每年6月在欧洲的一个主要城市举行，每年都有16000余名来自世界各地的代表参会，EULAR大会的科学计划涵盖了临床创新、临床、转化和基础科学等广泛的议题，是执业医师获取新的临床研究信息的最具创新性的平台。

欧洲抗风湿病联盟（EULAR）成立于1947年，是代表所有欧洲国家的风湿病科学协会、健康专业人士、关节炎/风湿病患者的非营利性科学教育协会，致力于促进和改善风湿与肌肉骨骼疾病(RMDs)的研究、预防、治疗和康复。EULAR现拥有45个科学学会会员，36个PARE组织和25个卫生专业人员协会以及26个企业成员。——未经本站许可，禁止复制转载镜像本站任何内容—领域国际医学会议网。

ABOUT THE EULAR EUROPEAN CONGRESS OF RHEUMATOLOGY

Since its introduction in 2000, the annual EULAR European Congress of Rheumatology has become the primary platform for exchange of scientific and clinical information in Europe. It is also a renowned forum for interaction between medical doctors, scientists, people with arthritis/rheumatism, health professionals and representatives of the pharmaceutical industry worldwide.

The scientific programme at the congress covers a wide range of topics on clinical innovations, clinical, translational and basic science. Meetings set up by associations of people with arthritis/rheumatism, health professionals and the health care industry complement the programme. The poster sessions, offering lively interaction between presenters and participants, are regarded by many as the heart of the congress.

Over the years, the EULAR Congress has gained a reputation of being a most innovative platform for the practicing physician particularly with respect to the acquisition of information on novel clinical research. The congress attracts more than 18,000 delegates from more than 130 countries.

The aim of the EULAR European Congress of Rheumatology is to provide a forum of the highest standard for scientific, both clinical and basic, educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with rheumatic diseases.

点此提交摘要>>>Submit Abstract>>>

EULAR 2021 Welcome message from the EULAR President

Dear Friends,

We live in the most interesting of times. Just as we long for the familiarity of prior years, so we are increasingly industrious, as we create our 'new reality' in the world of rheumatology. In so doing, we require remarkable flexibility and ingenuity as a discipline as we continue to combat the rheumatic and musculoskeletal diseases, and to care for those afflicted to the utmost of our ability.

The EULAR family is similarly changing rapidly, not least as we adapt to life with COVID-19. 2021 will bring our new structure into reality optimized for the 21st century. This will better equip us to deliver on our major objectives, enshrined in the EULAR 2023 Strategy . As we deliver on those objectives, we seek to deliver world class education, to provide penetrating and effective advocacy to our political classes, to offer empathetic and comprehensive support to patients and to sustain the discovery research efforts that will ultimately lead to cures for people with RMDs. In particular, in the last few months EULAR, working together with our valued international partners, has responded vigorously to the crisis in the creation of the EULAR-COVID-19 Database, the elaboration of timely patient information and the publication of our provisional 'COVID-19 management' recommendations - representing a living document to ensure their relevance in this fast changing pandemic environment.

A new congress approach for June 2021?

The EULAR Congress has always been at the centre of our activities - it provides a critical forum for education, knowledge exchange, research innovation, networking and especially fostering friendships! We were obliged to meet in the virtual world in 2020, forsaking our highly anticipated visit to Frankfurt.   Similarly, we plan to offer a ‘virtual congress’ in June 2021 though we hope to bring in twists of new experience. At its core, we will offer a virtual scientific and PARE programme that is outstanding – it will contain educational content that is contemporary, accessible and definitive. It will deliver research findings in the clinical, translational and basic domains that is world leading. It will provide online and in-person opportunities for networking, debate, engagement and feedback. Our faculty will represent the very best of global rheumatology. I offer one addendum to the above.  Our format will provide for predominantly virtual attendance.  

Regardless, our planning has been extensive already and conducted in close liaison with the relevant international and French authorities. I record here my personal appreciation of the extraordinary work ongoing on the part of the EULAR Secretariat as they bring imagination, energy and industry to the preparation of our Congress 2021. Similarly, my thanks in advance to the gifted scientific chairs and Congress committee members who are working so hard to deliver excellence.

I look forward to welcoming you to EULAR 2021, virtually, in June to celebrate all that is good in rheumatology!

Wishing you safe times.

Yours truly,

Iain B. McInnes
EULAR President

◆ 参会对象：医师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。